Skinvisible Stock Performance
| SKVI Stock | USD 0.38 0.02 5.00% |
Skinvisible holds a performance score of 5 on a scale of zero to a hundred. The entity has a beta of 0.0699, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Skinvisible's returns are expected to increase less than the market. However, during the bear market, the loss of holding Skinvisible is expected to be smaller as well. Use Skinvisible treynor ratio, as well as the relationship between the semi variance and day median price , to analyze future returns on Skinvisible.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Skinvisible are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, Skinvisible demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 35.9 K | |
| Total Cashflows From Investing Activities | -20.9 K | |
| Free Cash Flow | 353.7 K |
Skinvisible |
Skinvisible Relative Risk vs. Return Landscape
If you would invest 35.00 in Skinvisible on November 20, 2025 and sell it today you would earn a total of 3.00 from holding Skinvisible or generate 8.57% return on investment over 90 days. Skinvisible is currently generating 1.2248% in daily expected returns and assumes 16.6025% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Skinvisible, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Skinvisible Target Price Odds to finish over Current Price
The tendency of Skinvisible OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.38 | 90 days | 0.38 | about 60.93 |
Based on a normal probability distribution, the odds of Skinvisible to move above the current price in 90 days from now is about 60.93 (This Skinvisible probability density function shows the probability of Skinvisible OTC Stock to fall within a particular range of prices over 90 days) .
Skinvisible Price Density |
| Price |
Predictive Modules for Skinvisible
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Skinvisible. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Skinvisible's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Skinvisible Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Skinvisible is not an exception. The market had few large corrections towards the Skinvisible's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Skinvisible, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Skinvisible within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.83 | |
β | Beta against Dow Jones | 0.07 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | 0.05 |
Skinvisible Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Skinvisible for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Skinvisible can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Skinvisible is way too risky over 90 days horizon | |
| Skinvisible has some characteristics of a very speculative penny stock | |
| Skinvisible appears to be risky and price may revert if volatility continues | |
| Skinvisible currently holds 2.58 M in liabilities. Skinvisible has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Skinvisible until it has trouble settling it off, either with new capital or with free cash flow. So, Skinvisible's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Skinvisible sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Skinvisible to invest in growth at high rates of return. When we think about Skinvisible's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 663.43 K. Net Loss for the year was (1.07 M) with profit before overhead, payroll, taxes, and interest of 660.13 K. | |
| Latest headline from news.google.com: This Red Bank Dispensary Carries Strains Most NJ Shops Have Never Even Heard Of - TAPinto |
Skinvisible Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Skinvisible OTC Stock often depends not only on the future outlook of the current and potential Skinvisible's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Skinvisible's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.5 M | |
| Short Long Term Debt | 500.9 K | |
| Shares Float | 4.3 M |
Skinvisible Fundamentals Growth
Skinvisible OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Skinvisible, and Skinvisible fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Skinvisible OTC Stock performance.
| Return On Asset | 0.0678 | |||
| Profit Margin | (1.88) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 4.03 M | |||
| Shares Outstanding | 4.54 M | |||
| Price To Earning | 4.91 X | |||
| Price To Sales | 1.38 X | |||
| Revenue | 663.43 K | |||
| EBITDA | 158.23 K | |||
| Cash And Equivalents | 160.34 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 2.58 M | |||
| Debt To Equity | (1.07) % | |||
| Book Value Per Share | (1.38) X | |||
| Cash Flow From Operations | 374.61 K | |||
| Earnings Per Share | (0.19) X | |||
| Total Asset | 227.3 K | |||
| Retained Earnings | (27.83 M) | |||
| Current Asset | 97.12 K | |||
| Current Liabilities | 5.63 M | |||
About Skinvisible Performance
By evaluating Skinvisible's fundamental ratios, stakeholders can gain valuable insights into Skinvisible's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Skinvisible has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Skinvisible has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over the counter, personal skincare, and cosmetic arenas. Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada. Skinvisible operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 2 people.Things to note about Skinvisible performance evaluation
Checking the ongoing alerts about Skinvisible for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Skinvisible help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Skinvisible is way too risky over 90 days horizon | |
| Skinvisible has some characteristics of a very speculative penny stock | |
| Skinvisible appears to be risky and price may revert if volatility continues | |
| Skinvisible currently holds 2.58 M in liabilities. Skinvisible has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Skinvisible until it has trouble settling it off, either with new capital or with free cash flow. So, Skinvisible's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Skinvisible sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Skinvisible to invest in growth at high rates of return. When we think about Skinvisible's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 663.43 K. Net Loss for the year was (1.07 M) with profit before overhead, payroll, taxes, and interest of 660.13 K. | |
| Latest headline from news.google.com: This Red Bank Dispensary Carries Strains Most NJ Shops Have Never Even Heard Of - TAPinto |
- Analyzing Skinvisible's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Skinvisible's stock is overvalued or undervalued compared to its peers.
- Examining Skinvisible's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Skinvisible's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Skinvisible's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Skinvisible's otc stock. These opinions can provide insight into Skinvisible's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Skinvisible OTC Stock analysis
When running Skinvisible's price analysis, check to measure Skinvisible's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Skinvisible is operating at the current time. Most of Skinvisible's value examination focuses on studying past and present price action to predict the probability of Skinvisible's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Skinvisible's price. Additionally, you may evaluate how the addition of Skinvisible to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |